Series date: 
09/09/2024 - 4:00pm CDT to 06/30/2025 - 5:00pm CDT
Location

Please check the individual session for location or broadcast availability.  


Frequency

Weekly


Series Director

Erin Doherty, MD

Series Co-Director

Erin Morales, MD


Target Audience and Needs

Attending physicians, advanced practice providers, fellows, residents, and medical students in the fields of hematology-oncology and bone marrow transplantation need to receive regular updates on advances in hematopoietic stem cell transplantation and cellular therapies. Through reviews and appraisal of recent clinical trials, the series aims to expand the knowledge of learners, facilitate improvements in the treatment of immunodeficiencies and hematological malignancies and disorders, enhance the quality of hematology-oncology care, reduce treatment-related morbidity and mortality related to stem cell transplant, and improve patient outcomes.


Educational Methods

Educational methods will include literature review.


Objectives

At the conclusion of the sessions, the participants should be able to:

  • Identify seminal studies related to hematopoietic stem cell transplantation and cellular therapies.
  • Appraise these studies for relevancy, validity, and clinical applicability.
  • State the principles of evidence-based medicine.
  • Translate evidence-based research findings into clinical practice.

Evaluation

Participants may be asked to complete a session evaluation.


Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Series Coordinator 
Clarissa Vasquez
cxvasque@texaschildrens.org
832-824-4671
Series location: 
Texas Children's Hospital
6621 Fannin Street
Houston, TX 77030
United States

Sessions

Session Date
Literature Review: Efficacy of Azacitidine and Prophylactic Donor Lymphocyte Infusion after HSCT in Pediatric Patients with Acute Myelogenous Leukemia: A Retrospective Pre-Post Study 11/11/2024 - 4:00pm to 5:00pm CST
Literature Review: Verification of the Prediction Accuracy of a Biomarker-Based Prognostic for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome After Hematopoietic Cell Transplantation 12/16/2024 - 4:00pm to 5:00pm CST
Literature Review: Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis 02/10/2025 - 4:00pm to 5:00pm CST
Literature Review: Mapping The Cellular Biogeography of Human Bone Marrow Niches Using Single-Cell Transcriptomics and Proteomic Imaging 03/17/2025 - 4:00pm to 5:00pm CDT
Literature Review: Everolimus with or without Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis after Hematopoietic Stem Cell Transplantation in Children with Acute Kidney Injury 04/14/2025 - 4:00pm to 5:00pm CDT
Literature Review: Soluble Thrombomodulin Is Associated with Endothelial Dysfunction Syndromes after Pediatric Hematopoietic Stem Cell Transplantation 05/12/2025 - 4:00pm to 5:00pm CDT
Literature Review: Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival 06/16/2025 - 4:00pm to 5:00pm CDT